Victoria Johnson - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Victoria Johnson's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Victoria Johnson

Victoria Johnson

Verified

Associate Editor, CGTLive

Final Covers

Opinion and Editorial, Food and Dining Arts and Entertainment, Sports Current Events,Celebrities

Doesn’t Cover

The list is long.

Journalist Type

-

Seniority Positions

Industries

Medium Formats

-

Content

Total articles 1096

  • A different dimension: a comparison between 2D cell lines and 3D organoids in cancer drug screening cell viability​

    By Payton Curran, Delaney Anderson, Victoria Johnson Verified, Isaac Packer| scholarsarchive.byu.edu@ Download Download Full Text (823 KB) Cancer, Drug, 2D cells vs. 3D organioids Curran, Payton; Packer, Isaac; Anderson, DeLaney; Johnson, VIctoria; Okojie, Jeffery; and Barrott, Jared, "A different dimension: a comparison between 2D cell lines and 3D organoids in cancer drug screening cell viability​" (2025). Library/Life Sciences Undergraduate Poster Competition 2025. 74. https://scholarsarchive.byu.edu/library_studentposters_2025/74 Cell Biology and Physiology

    By Payton Curran, Delaney Anderson, Victoria Johnson Verified, Isaac Packer · scholarsarchive.byu.edu

    Mar. 27, 2025

  • Steven W. Pipe, MD, on Evaluating siRNA Therapy Fitusiran in Combination With Antithrombin Modulation for Hemophilia

    By Steven W Pipe, Victoria Johnson Verified| CGTLive@ This interview originally appeared on our sister site, HCPLive®. "Fitusiran is a highly effective prophylactic agent. The modulation of thrombin generation allows us to achieve effective bleed control with substantially lower doses of factor and bypassing agents, as well as fewer infusions.

    By Steven W Pipe, Victoria Johnson Verified · CGTLive

    Dec. 11, 2024

  • A different dimension: a comparison between 2D cell lines and 3D organoids in cancer drug screening cell viability​

    By Payton Curran, Delaney Anderson, Victoria Johnson Verified, Isaac Packer| scholarsarchive.byu.edu@ Download Download Full Text (823 KB) Cancer, Drug, 2D cells vs. 3D organioids Curran, Payton; Packer, Isaac; Anderson, DeLaney; Johnson, VIctoria; Okojie, Jeffery; and Barrott, Jared, "A different dimension: a comparison between 2D cell lines and 3D organoids in cancer drug screening cell viability​" (2025). Library/Life Sciences Undergraduate Poster Competition 2025. 74. https://scholarsarchive.byu.edu/library_studentposters_2025/74 Cell Biology and Physiology

    By Payton Curran, Delaney Anderson, Victoria Johnson Verified, Isaac Packer · scholarsarchive.byu.edu

    Mar. 27, 2025

As seen in

Company Info

CGTLive

NeurologyLive is a multimedia platform focused on delivering the latest news and insights in the field of neurology. It serves as a valuable resource for healthcare professionals, particularly those treating neurological diseases. The platform offers a combination of print and digital media, ensuring that busy clinicians stay informed about significant developments in neurology. The services provided by NeurologyLive include breaking news on drug approvals, clinical trials, and emerging trends in neurological care. It features expert interviews with leading neurologists, offering insights into the latest research and clinical practices. The use of multimedia content makes the information accessible and engaging for its audience. NeurologyLive targets healthcare professionals such as neurologists, clinicians, and researchers. It has established strategic partnerships with organizations like the Consortium of Multiple Sclerosis Centers, enhancing its credibility and reach within the neurology community. Its comprehensive coverage and expert engagement position NeurologyLive as a trusted source for the latest developments in the field.

Cranbury, United States

+1 609-716-7777

Founded: 2018